Becton Dickinson’s TBNK Multitest Cleared for High-Risk COVID Patients

Becton Dickinson’s (BD) BD Multitest 6-Color TBNK Reagent with BD Trucount Tubes has received CE mark certification that allows it to be used in identifying high-risk COVID-19 patients.

The CE mark clears the test for assessing COVID-19 patients’ T-cell levels, which enables it to identify those at increased risk of death after hospitalization and those at risk of requiring mechanical ventilation.

BD’s test is used with the company’s FACSLyric and FACSCanto II clinical-flow cytometers.